KD Nutra?, a KD Pharma Group Company

Today is a historic day for our company. We are thrilled to announce that the KD Pharma Group has successfully completed the acquisition of the Marine Lipids omega-3 business of dsm-firmenich. As a fully vertically integrated manufacturer of nutritional lipid solutions, we have become the largest and most competitive omega-3 company in the world. With new, elevated capabilities, we are now better positioned to fulfill our mission of creating innovative health solutions that help people live better lives! Please join us in welcoming our new colleagues, customers, and partners. Read more: https://lnkd.in/ehahWx_T #omega3 #epa #dha #acquisitions #fishoil #peru #canada #investors

We are proud to introduce ???? ???????????????????????, Omega-3 Testing Laboratory and Analytics. With almost four decades of experience as an omega-3 manufacturer, we have established ourselves as a trusted partner to companies around the world in the pharmaceutical, food and dietary supplement industries. We have decided to offer our high-precision analysis as a professional, independent laboratory service to meet the need for reliable omega-3 laboratory services. KD LabService? is a ??????????-?????????? ???????????????????? that provides highly accurate lipid analysis of omega-3 oils under #cGMP conditions. We are very proud of the special mention on the GOED’s website promoting our services (GOED Special Achievement Program (GOED Special Achievement Program (goedomega3.com), a mention received thanks to the outstanding results on the quantification of #EPA and #DHA achieved in the GOED AOCS Laboratory Proficiency Program in 2023-2024. We can't wait to see the great success of our laboratory testing service, KD LabService? #analyticalservices #omega3 #omega3testing #labservices #fishoil

KD Pharma Group announces acquisition of dsm-firmenich’s marine lipids business in exchange for a minority stake in the company. ? The KD Pharma Group, a leading CDMO in pharmaceutical and nutritional lipids, and dsm-firmenich, innovators in nutrition, health, and beauty, announce today the sale of dsm-firmenich’s Marine Lipids business to the KD Pharma Group in exchange for a minority stake in the enlarged KD company. ?? The transaction will happen in the course of 2024 and includes dsm-firmenich’s Marine Lipids fish oil Omega-3 business for the Food & Beverage, Dietary Supplement and Pharma markets, together with the MEG-3? brand and production facilities in Piura, Peru and Mulgrave, Canada. This transaction will create a well-equipped market player in Marine Lipids by combining the best of the two companies and respective expertise, with the scale of dsm-firmenich’s Piura and Mulgrave sites and the high concentration capability of the KD Pharma Group company.?The enlarged KD Pharma Group company will benefit from the expansion into a significantly wider range of products and customization opportunities supported by broadened manufacturing capacity. dsm-firmenich will continue to offer MEG-3? fish oils for the Early Life Nutrition markets as well as MEG-3? powders. Oscar Groet, CEO of the KD Pharma Group said, “We are thrilled to welcome dsm-firmenich’s Marine Lipids portfolio into the KD Pharma Group, a move that aligns perfectly with our strategic vision of being technology leaders in lipids and enhancing our ability to innovate and deliver exceptional value to our customers." This transaction is expected to be completed towards the end of 2024, and is subject to customary regulatory approvals. #fishoil #omega3 #acquisitions #investors #marinelipids #innovation #EPA #DHA #supplements